kr329.20
0.96% today
Stockholm, Nov 05, 11:59 am CET
ISIN
SE0000872095
Symbol
SOBI

Swedish Orphan Biovitrum Stock price

kr332.40
+17.40 5.52% 1M
+35.80 12.07% 6M
+15.00 4.73% YTD
-2.80 0.84% 1Y
+122.90 58.66% 3Y
+171.70 106.85% 5Y
+201.90 154.71% 10Y
+220.90 198.12% 20Y
Stockholm, Closing price Tue, Nov 04 2025
+8.80 2.72%
ISIN
SE0000872095
Symbol
SOBI
Industry

New AI Insights on Swedish Orphan Biovitrum Insights AI Insights on Swedish Orphan Biovitrum

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
kr111.6b
Enterprise Value
kr124.1b
Net debt
kr12.6b
Cash
kr1.0b
Shares outstanding
344.7m
Valuation (TTM | estimate)
P/E
8,310.0 | 23.3
P/S
4.0 | 3.9
EV/Sales
4.5 | 4.3
EV/FCF
29.5
P/B
3.1
Financial Health
Equity Ratio
53.4%
Return on Equity
9.6%
ROCE
19.9%
ROIC
-0.1%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
kr27.9b | kr28.7b
EBITDA
kr20.7b | kr10.6b
EBIT
kr10.5b | kr6.9b
Net Income
kr14.0m | kr4.9b
Free Cash Flow
kr4.2b
Growth (TTM | estimate)
Revenue
9.5% | 10.1%
EBITDA
118.5% | 11.0%
EBIT
76.9% | 18.9%
Net Income
-99.6% | 26.5%
Free Cash Flow
29.3%
Margin (TTM | estimate)
Gross
78.2%
EBITDA
74.2% | 36.9%
EBIT
37.8%
Net
0.1% | 17.2%
Free Cash Flow
15.1%
More
EPS
kr0.0
FCF per Share
kr12.2
Short interest
-
Employees
2k
Rev per Employee
kr13.7m
Show more

Is Swedish Orphan Biovitrum a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.

Swedish Orphan Biovitrum Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Swedish Orphan Biovitrum forecast:

13x Buy
68%
5x Hold
26%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a Swedish Orphan Biovitrum forecast:

Buy
68%
Hold
26%
Sell
5%

Financial data from Swedish Orphan Biovitrum

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
27,851 27,851
9% 9%
100%
- Direct Costs 6,075 6,075
12% 12%
22%
21,776 21,776
9% 9%
78%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
20,670 20,670
118% 118%
74%
- Depreciation and Amortization 10,144 10,144
189% 189%
36%
EBIT (Operating Income) EBIT 10,526 10,526
77% 77%
38%
Net Profit 14 14
100% 100%
0%

In millions SEK.

Don't miss a Thing! We will send you all news about Swedish Orphan Biovitrum directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceutical. The firm focuses on the hematology and immunology therapeutic areas. It also offers specialty treatments in the area of genetics and metabolism. The company was founded in 2001 and is headquartered in Solna, Sweden.

Head office Sweden
CEO Guido Oelkers
Employees 1,895
Founded 2001
Website www.sobi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today